<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20171229038128N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2018-03-10</date_registration>
      <primary_sponsor>Golestan University of Medical Science</primary_sponsor>
      <public_title>The effect of Intra Masseter Dexamethasone Injection on Postoperative Complications after Impacted and Semi Impacted Third Molar Surgery</public_title>
      <acronym>TMDC</acronym>
      <scientific_title>The effect of Intra Masseter Dexamethasone Injection on Postoperative Complications (pain, oedema and trismus) after Impacted and Semi Impacted Third Molar Surgery: A split-mouth randomized trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2018-02-20</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>19</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/29181</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Double blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: This study is based on split-mouth randomized clinical trial and will be performed to evaluate the effect of intra -Masseter dexamethasone injection on the outcomes of post-operative bilateral third molars. The most important goal of this commonly used method in interventional studies Split-Mouth Design is the elimination of inter-subject variability, because each person is self-controlled. Therefore, in this type of study, randomization occurs on teeth or oral areas rather than on patients, Randomization description: In this type of study, randomization occurs rather than on patients, oral surgery occurs or oral areas occur. Random allocation method will be performed on a simple random type (random number list). A randomized list will be prepared by an epidemiologist who is not involved in the implementation of the interventions, Blinding description: Patients and assessing the outcomes of the study (pain, swelling and trismus) do not know the random allocation of oral areas.</study_design>
      <phase>3</phase>
      <hc_freetext>Postoperative Complications  after Impacted and Semi Impacted Third Molar Surgery.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group:On one side of the oral surgery, dexamethasone injection of 8 mg, half an hour before surgery, and IM into the muscle of the master and will be performed by the surgeon. Intervention 2: Control group:The other side of the mouth is not injected dexamethasone prior to the third molar surgery (all surgical conditions such as the oral side of the intervention except dexamethasone injection).</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All data are available after Unrecognizable

When:
6 month after printing

To whom:
Academic institutions

Conditions:
Research plan

Where to obtain:
Dental school of Golestan University of Medicine Scinces

How to obtain:
Submit an application to research department of dental school

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mohamadali Rahnama</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental clinic of Golestan University of Medical Science, Obverse Edalat 97 alley, Naharkhoran Blv, Gorgan,Iran</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4916953358</zip>
        <telephone>+98 17 3255 0565</telephone>
        <email>m.rahnama@goums.ac.ir</email>
        <affiliation>Golestan Universities of Medical Science</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mohamadali Rahnama</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Dental clinic of Golestan University of Medical Science, Obverse Edalat 97 alley, Naharkhoran Blv, Gorgan,Iran</address>
        <city>Gorgan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>4916953358</zip>
        <telephone>+98 17 3255 0565</telephone>
        <email>m.rahnama@goums.ac.ir</email>
        <affiliation>Golestan Universities of Medical Science</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>20 to 45 years of age
Third mandibular molar impaction in both side
Kind of impaction and difficulty in both impacted tooth be even ( both semi-impacted or both impacted and situation of impaction be even)</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>45 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Using of interventionist medications with healing process
Having systemic disorders
Having oral and maxillofacial disease or trauma to the region
Having infection of pericoronitis in field of surgery
History of allergy to lidocaine  or other drugs
Manifestation of any allergic reaction, sensibility increase or immunosyncratic to the drugs Definition of intervention group: Another side of the mouth that surgery is performing half our before surgery is injected by intramasseter dexamethasone. Definition of control group: Another side of the moth that surgery is performing half our before surgery is not injected by dexamethasone (all situation is the same except injection of dexamethasone)</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Treatment - Surgery</i_code>
      <i_code>Treatment - Surgery</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:On one side of the oral surgery, dexamethasone injection of 8 mg, half an hour before surgery, and IM into the muscle of the master and will be performed by the surgeon</i_keyword>
      <i_keyword>Control group:The other side of the mouth is not injected dexamethasone prior to the third molar surgery (all surgical conditions such as the oral side of the intervention except dexamethasone injection).</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pain. Timepoint: 2 and 7 days after intervention. Method of measurement: VAS(Visual Analogue Scale ).</prim_outcome>
      <prim_outcome>Swelling. Timepoint: 2 and 7 days after intervention. Method of measurement: Swelling is measured using the reference points (lower abdomen of the lobe of the ear to the corner of the mouth and the lateral edges of the eye to the mandible corner), through a flexible ruler (a dial pad for a more accurate measurement of the curved areas) and the vignette. The caliber is made up of a combination of a dial pad and a movable veneer. The vernier ruler has two antennas, small tentacles for measuring the inside diameter and large tentacles for measuring the external diameter of the objects). Will be evaluated.</prim_outcome>
      <prim_outcome>(Trismus). Timepoint: 2 and 7 days after intervention. Method of measurement: The Trismus value will be measured by measuring the maximum distance between the two maxillary and maxillary maxillary incisors by the ventricular calcium.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Golestan University of Medical Science</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2017-12-17</approval_date>
        <contact_name>Ethics committee of Golestan University of Medical Sciences</contact_name>
        <contact_address>Dental clinic of Golestan University of Medical Science, Obverse Edalat 97 alley, Naharkhoran Blv, Gorgan,Iran Gorgan Golestan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
